The Basis of Anthrax-Induced Vascular Damage
The Basis of Anthrax-Induced Vascular Damage
批准号:
6985044
负责人:
JAMES E KIRBY
金额:
$21.25万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-06-15 至 2007-05-31
关键词:
Bacillus anthracisanthraxanthrax toxinapoptosisbacteria infection mechanismbioterrorism /chemical warfareblood vessel disorderdisease /disorder modeledemaelectron microscopyhemorrhagehistopathologyhost organism interactioninflammationlaboratory mousepathologic processthrombosisvascular endothelium permeability
中文摘要
描述(由申请人提供):炭疽芽孢杆菌感染导致出血、组织肿胀和血栓形成,对炭疽疾病和死亡有重要影响。因此,我们的长期目标是开发针对这些事件的血管损伤的治疗方法。为了建立这些疗法的科学基础,本提案将使用小鼠模型在结构和分子水平上表征炭疽诱导的血管损伤。在第一个目标中,我们将通过组织学时间过程研究来确定急性血管损伤的超微结构基础。作为这一目标的一部分,炭疽致死毒素和水肿毒素对血管病理学的贡献也将被确定。第二个目标将通过分析和调节已知的其他系统中导致血管病理的途径来探索血管损伤的生理基础。为了与R21资助机制的探索性保持一致,本目标将调查一些可能的情况,从而通过积极和消极的发现让我们更全面地了解。作为这项探索的一部分,我们希望确定并测试新的治疗策略。
英文摘要
DESCRIPTION (provided by applicant): Infection with Bacillus anthracis leads to bleeding, tissue swelling, and thrombosis, contributing significantly to illness and death from anthrax. Therefore, our long-term objective is to develop therapies targeting vascular damage underlying these events. To establish the scientific basis for these therapies, this proposal will use a murine model to characterize anthrax-induced vascular damage at a structural and molecular level. In the first aim, we will define the ultrastructural basis for acute vascular damage through histological time course studies. As part of this aim, the contributions of anthrax lethal toxin and edema toxin towards vascular pathology will also be determined. The second aim will explore the physiological basis for vessel damage through analysis and modulation of pathways known to contribute to vascular pathology in other systems. In keeping with the exploratory nature of the R21 funding mechanism, this aim will survey a number of possible scenarios, thereby giving us a more complete understanding through both positive and negative findings. As part of this exploration, we hope to identify and test new therapeutic strategies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
De Novo Synthesis, and Functional and Structural Characterization of Novel Aminoglycoside Analogues to Bypass Resistance Mechanisms and Optimize Selectivity
-
批准号:10676201
-
项目类别:
-
资助金额:$75.72万
-
财政年份:2020
-
负责人:JAMES E KIRBY
-
依托单位:
Use of De Novo Synthesis Approaches and Structure-guided Design to Optimize Therapeutic Properties of Streptothricin Class Antimicrobials
-
批准号:10469007
-
项目类别:
-
资助金额:$77.22万
-
财政年份:2020
-
负责人:JAMES E KIRBY
-
依托单位:
De Novo Synthesis, and Functional and Structural Characterization of Novel Aminoglycoside Analogues to Bypass Resistance Mechanisms and Optimize Selectivity
-
批准号:10447128
-
项目类别:
-
资助金额:$76.53万
-
财政年份:2020
-
负责人:JAMES E KIRBY
-
依托单位:
Use of De Novo Synthesis Approaches and Structure-guided Design to Optimize Therapeutic Properties of Streptothricin Class Antimicrobials
-
批准号:10269053
-
项目类别:
-
资助金额:$77.75万
-
财政年份:2020
-
负责人:JAMES E KIRBY
-
依托单位:
Use of De Novo Synthesis Approaches and Structure-guided Design to Optimize Therapeutic Properties of Streptothricin Class Antimicrobials
-
批准号:10686110
-
项目类别:
-
资助金额:$76.68万
-
财政年份:2020
-
负责人:JAMES E KIRBY
-
依托单位:
De Novo Synthesis, and Functional and Structural Characterization of Novel Aminoglycoside Analogues to Bypass Resistance Mechanisms and Optimize Selectivity
-
批准号:10242923
-
项目类别:
-
资助金额:$77.26万
-
财政年份:2020
-
负责人:JAMES E KIRBY
-
依托单位:
Fusidic acid derivatization to enhance entry into Gram-negative pathogens
-
批准号:9807473
-
项目类别:
-
资助金额:$26.61万
-
财政年份:2019
-
负责人:JAMES E KIRBY
-
依托单位:
VALIDATION OF A HIGH THROUGHPUT SCREEN FOR KPC PLASMID EVICTION
-
批准号:8891557
-
项目类别:
-
资助金额:$21.75万
-
财政年份:2015
-
负责人:JAMES E KIRBY
-
依托单位:
Plasmid Eviction to Restore Susceptibility in Carbapenem-Resistant Enterobacteriaceae
-
批准号:8954519
-
项目类别:
-
资助金额:$13.05万
-
财政年份:2015
-
负责人:JAMES E KIRBY
-
依托单位:
VALIDATION OF A HIGH THROUGHPUT SCREEN FOR KPC PLASMID EVICTION
-
批准号:8990439
-
项目类别:
-
资助金额:$26.1万
-
财政年份:2015
-
负责人:JAMES E KIRBY
-
依托单位:
Novel Antimicrobials Targeting Bacterial Type IV Secretion Systems
-
批准号:8439168
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2012
-
负责人:JAMES E KIRBY
-
依托单位:
Novel Antimicrobials Targeting Bacterial Type IV Secretion Systems
-
批准号:9123514
-
项目类别:
-
资助金额:$39.15万
-
财政年份:2012
-
负责人:JAMES E KIRBY
-
依托单位:
Novel Antimicrobials Targeting Bacterial Type IV Secretion Systems
-
批准号:8549945
-
项目类别:
-
资助金额:$36.8万
-
财政年份:2012
-
负责人:JAMES E KIRBY
-
依托单位:
Type IV Secretion System Therapeutics
-
批准号:7896197
-
项目类别:
-
资助金额:$21.71万
-
财政年份:2010
-
负责人:JAMES E KIRBY
-
依托单位:
Type IV Secretion System Therapeutics
-
批准号:8041056
-
项目类别:
-
资助金额:$25.84万
-
财政年份:2010
-
负责人:JAMES E KIRBY
-
依托单位:
Non-Antibiotic Selectable Markers for Bacillus Anthracis
-
批准号:7565913
-
项目类别:
-
资助金额:$34.83万
-
财政年份:2008
-
负责人:JAMES E KIRBY
-
依托单位:
Non-Antibiotic Selectable Markers for Bacillus Anthracis
-
批准号:7472107
-
项目类别:
-
资助金额:$21.25万
-
财政年份:2008
-
负责人:JAMES E KIRBY
-
依托单位:
The Basis of Anthrax-Induced Vascular Damage
-
批准号:7140530
-
项目类别:
-
资助金额:$20.75万
-
财政年份:2005
-
负责人:JAMES E KIRBY
-
依托单位:
LEGIONELLA PNEUMOPHILA VIRULENCE FACTORS DEFINED IN VIVO
-
批准号:2442371
-
项目类别:
-
资助金额:$8.26万
-
财政年份:1996
-
负责人:JAMES E KIRBY
-
依托单位:
LEGIONELLA PNEUMOPHILA VIRULENCE FACTORS DEFINED IN VIVO
-
批准号:2886030
-
项目类别:
-
资助金额:$0.55万
-
财政年份:1996
-
负责人:JAMES E KIRBY
-
依托单位:
海外基金